Evidence map›Paper›PMID 23041265›Full record

ReviewExperimental and molecular pathology2012

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.

Guoping Deng, Yan Xiao, Zhaocai Zhou, Yasuhiro Nagai, Hongtao Zhang, Bin Li, Mark I Greene

Abstract readReview
In one paragraph

Review in Experimental and molecular pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEX.Advances in experimental medicine and biology · 2021
    Article
  4. Activation ofFrontiers in immunology · 2021
    Article
  5. Review
  6. Case Report:Frontiers in immunology · 2021
    Article
  7. FoxP3 in TClinical and experimental immunology · 2020
    Review
  8. Article
  9. Article
  10. Review
  11. Tumor-infiltrating regulatory T cells: origins and features.American journal of clinical and experimental immunology · 2018
    Review
  12. The regulation of immune tolerance by FOXP3.Nature reviews. Immunology · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Guoping DengDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104-6082, USA.
Yan Xiao
Zhaocai Zhou
Yasuhiro Nagai
Hongtao Zhang
Bin Li
Mark I Greene
University of Pennsylvania · USCenter for Excellence in Molecular Cell Science · CNInstitut Pasteur of Shanghai · CN

Funding

Transgenic and mutant animalP01AI073489 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI KATSUMATA, MAKOTO · 2008 to 2012
$7.1M
NIAID NIH HHS P01 AI073489NIAID NIH HHS P01 AI073489-03
6 · The paper itself

Abstract

Regulatory T (Treg) cells are essential in preventing the host from developing certain autoimmune diseases and limiting excessive immune responses against pathogens. The normal function of most Treg cells requires sustained expression of functional FOXP3, a member of the FOXP family transcription factors. FOXP3 is distinct from other subfamily members because of its unique proline rich amino (N)-terminal domain. Mutations in this region are occasionally identified in certain patients with X-linked autoimmunity-allergic dysregulation syndrome (XLAAD) and similar mutations also increase susceptibility of autoimmune diseases in rodent models. Previous analyses of the FOXP3 N-terminal domain revealed a role in nuclear import, interaction with other transcription factors, and as sites of specific post-translational modifications of FOXP3 that contribute to FOXP3 stability.

Indexed as

AnimalsDisease Models, AnimalForkhead Transcription FactorsGenetic Diseases, X-LinkedGenetic Predisposition to DiseaseHost-Pathogen InteractionsHumansImmunity, InnateMiceMutationProtein Processing, Post-TranslationalT-Lymphocytes, RegulatoryForkhead Transcription FactorsFOXP3 protein, human

Identifiers

PMID23041265
PMCPMC3518637
OpenAlexW2015558152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.